Kampo medicine for <scp>COVID</scp>‐19 prevention, treatment, and recovery in clinical and pharmacological aspect-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Kampo medicine for COVID‐19 prevention, treatment, and recovery in clinical and pharmacological aspect

Published:2023-02-15 Issue:1 Volume:10 Page:75-77
ISSN:2053-4515
Container-title:Traditional & Kampo Medicine
language:en
Short-container-title:Traditional & Kampo Medicine

Author:

Takayama Shin¹^ORCID,Namiki Takao²^ORCID,Makino Toshiaki³^ORCID,Arita Ryutaro¹,Odaguchi Hiroshi⁴,Ito Takashi⁵

Affiliation:

1. Department of Education and Support for Regional Medicine Tohoku University Hospital Sendai Japan

2. Department of Japanese‐Oriental (Kampo) Medicine, Graduate School of Medicine Chiba University Chiba Japan

3. Graduate School of Pharmaceutical Sciences Nagoya City University Nagoya Japan

4. Oriental Medicine Research Center Kitasato University Minato‐ku Japan

5. Japanese Society for Oriental Medicine Tokyo Japan

Publisher

Wiley

Subject

Environmental Engineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/tkm2.1361

Reference5 articles.

1. Basic pharmacological mechanisms and clinical evidence of the efficacy of hochuekkito against infectious diseases and its potential for use against COVID‐19

2. Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID ‐19

3. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)

4. Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)

5. Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3